ArticleMolecular pharmaceutics2014

Re-engineered p53 chimera with enhanced homo-oligomerization that maintains tumor suppressor activity.

Abood Okal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.